E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 12/20/2005 in the Prospect News Biotech Daily.

Schering to raise dividend by 20%

New York, Dec. 20 - Schering AG said it plans to increase the dividend on its common stock by 20% over the previous year's level.

The Berlin, Germany, pharmaceutical company said the higher level reflects "continuous positive business development in 2005."

Shareholders will be asked to approve the payment of €1.20 per share at the annual general meeting on April 19.

Schering also said it has settled with Bayer AG a dispute over warranty claims asserted by Bayer. This settlement relates to the sale of Schering's stake in the plant protection company Aventis CropScience in 2002.

The settlement will result in Schering reversing provisions that will cause a one-time benefit of €70 million to €100 million.

That positive influence will partially compensate for potential negatives, Schering said. These include charges from restructuring measures related to Schering's Focus program.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.